Replies to post #7421 on Mast Therapeutics, Inc. (MSTX)

[SC 388]

Hi Zigzagman: My Belief in ANX

Actually, I found your Blog that showed me your opinion on the potential buyout, which I read before. I regularly check your blog on http://www.stock-market-lessons.com/

http://day-trading-the-stock-market.blogspot.com/search?updated-min=2010-02-01T00%3A00%3A00-06%3A00&updated-max=2010-03-01T00%3A00%3A00-06%3A00&max-results=14

Even though a high-profit generating buyout deal doesn't happen soon, I really believe in ANX's future mainly because of the following:

(1) Brian Culley's Ability & Commitment
(2) ANX-530: Bioequivalence has been already established.
(3) ANX-514: Pre-clinical bioequivalence confirmation by President & CEO of Shin Poong Pharma and its commitment to a successful "clinical" bioequivalence study. Shin Poong Pharma has been in business since 1962 and has become a very reputable company in S. Korea with more than 1,500 employees. They believe in emulsion technology. Mr. Kim said on 12-1-2009, "Our independent confirmation of the bioequivalence and comparable overall safety of ANX-514 and Taxotere affirm our belief in both the emulsion platform technology underlying several ADVENTRX product candidates and its application to docetaxel,"
(4) Carl Icahn will make sure that ANX investors and himself will be profitable from this investment.

Good Luck to all sincere investors.